Novo Nordisk Price Target Rises to $80 as Oral Wegovy Surpasses 3 Million Prescriptions
Novo Nordisk received an upgraded price target of $80, while market analysts assigned the stock a Modest Buy rating….
-
-
MindRank Secures Fifty-Two Million Series B for Oral GLP-1 Candidate
MindRank, a drug discovery company that uses artificial intelligence, recently completed a fifty-two million dollar Series B financing round….
-
Novo Nordisk Oral Wegovy Strengthens Obesity Market
Novo Nordisk recorded over three million prescriptions for oral Wegovy within five months of its availability. Financial analysts gave…
-
Clinical Trial Confirms Significant Weight Loss for Investigational Oral GLP-1 Therapy
An investigational once-daily pill designed to activate the GLP-1 receptor produced measurable weight loss in a mid-stage clinical trial….
-
Corxel-Vincentage’s Oral GLP-1 Achieves Positive Phase II Obesity Trial Results
Obesity medicine is changing fast as companies work on making weight-loss pills instead of just shots. Corxel Pharmaceuticals and…
-
Oral GLP-1s at the Bench: Moving from Pens to Pills
The GLP-1 receptor agonist class started when national regulators approved exenatide for diabetes management. Researchers first developed these molecules…
-
Oral GLP-1 Drugs Advance as Pharmaceutical Companies Race Toward Pill-Based Weight Loss Treatments
Multiple pharmaceutical companies are developing oral versions of GLP-1 receptor agonists. This class of drugs has changed the treatment…
-
Novo Nordisk Discloses Cybersecurity Breach Amid Push for Oral Wegovy Approval in China
Novo Nordisk is dealing with a major security headache after hackers broke into their systems and stole private patient…
-
Zepbound and Wegovy: Is There a Perfect Time to Take Them?
Embarking on a medical weight loss journey with treatments like Zepbound or Wegovy is a massive milestone toward reclaiming…
-
Structure Therapeutics’ Oral GLP-1 Candidate Aleniglipron Posts 16.2% Weight Loss in Phase 2 Trial
Structure Therapeutics just shared exciting new results from a mid-stage clinical trial for its experimental weight loss pill, aleniglipron….
